1. Home
  2. BCDA vs SCKT Comparison

BCDA vs SCKT Comparison

Compare BCDA & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • SCKT
  • Stock Information
  • Founded
  • BCDA N/A
  • SCKT 1992
  • Country
  • BCDA United States
  • SCKT United States
  • Employees
  • BCDA N/A
  • SCKT N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • SCKT Computer Manufacturing
  • Sector
  • BCDA Health Care
  • SCKT Technology
  • Exchange
  • BCDA Nasdaq
  • SCKT Nasdaq
  • Market Cap
  • BCDA 9.4M
  • SCKT 8.3M
  • IPO Year
  • BCDA N/A
  • SCKT 1995
  • Fundamental
  • Price
  • BCDA $3.25
  • SCKT $1.11
  • Analyst Decision
  • BCDA Strong Buy
  • SCKT
  • Analyst Count
  • BCDA 1
  • SCKT 0
  • Target Price
  • BCDA $60.00
  • SCKT N/A
  • AVG Volume (30 Days)
  • BCDA 57.6K
  • SCKT 7.2K
  • Earning Date
  • BCDA 08-07-2024
  • SCKT 07-31-2024
  • Dividend Yield
  • BCDA N/A
  • SCKT N/A
  • EPS Growth
  • BCDA N/A
  • SCKT N/A
  • EPS
  • BCDA N/A
  • SCKT N/A
  • Revenue
  • BCDA $468,000.00
  • SCKT $17,699,212.00
  • Revenue This Year
  • BCDA N/A
  • SCKT $10.78
  • Revenue Next Year
  • BCDA $436.41
  • SCKT $8.00
  • P/E Ratio
  • BCDA N/A
  • SCKT N/A
  • Revenue Growth
  • BCDA N/A
  • SCKT N/A
  • 52 Week Low
  • BCDA $2.62
  • SCKT $0.90
  • 52 Week High
  • BCDA $39.60
  • SCKT $1.59
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 42.62
  • SCKT 44.08
  • Support Level
  • BCDA $2.62
  • SCKT $1.08
  • Resistance Level
  • BCDA $3.38
  • SCKT $1.18
  • Average True Range (ATR)
  • BCDA 0.30
  • SCKT 0.05
  • MACD
  • BCDA 0.11
  • SCKT 0.01
  • Stochastic Oscillator
  • BCDA 82.88
  • SCKT 40.33

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, out of which the majority of the revenue is generated from the United States.

Share on Social Networks: